-
Corrigendum: Clinical Investigation (2015) Vol 5, Iss 12.
Corrigendum: Clinical Investigation
-
Corrigendum: Clinical Investigation (2015) Vol 5, Iss 12.
Corrigendum: Clinical Investigation
-
Corrigendum: Clinical Investigation (2015) Vol 5, Iss 12.
Corrigendum: Clinical Investigation
-
Corrigendum: Clinical Investigation (2015) Vol 5, Iss 12.
Corrigendum: Clinical Investigation
-
Corrigendum: Clinical Investigation (2015) Vol 5, Iss 12.
Corrigendum: Clinical Investigation
-
Corrigendum: Clinical Investigation (2015) Vol 5, Iss 12.
Corrigendum: Clinical Investigation
-
Corrigendum: Clinical Investigation (2015) Vol 5, Iss 12.
Corrigendum: Clinical Investigation
-
Corrigendum: Clinical Investigation (2015) Vol 5, Iss 12.
Corrigendum: Clinical Investigation
-
There should be only one priority in clinical research-to put the needs of the consumer first
Simon Denegri
Editorial: Clinical Investigation
-
There should be only one priority in clinical research-to put the needs of the consumer first
Simon Denegri
Editorial: Clinical Investigation
-
There should be only one priority in clinical research-to put the needs of the consumer first
Simon Denegri
Editorial: Clinical Investigation
-
There should be only one priority in clinical research-to put the needs of the consumer first
Simon Denegri
Editorial: Clinical Investigation
-
There should be only one priority in clinical research-to put the needs of the consumer first
Simon Denegri
Editorial: Clinical Investigation
-
There should be only one priority in clinical research-to put the needs of the consumer first
Simon Denegri
Editorial: Clinical Investigation
-
There should be only one priority in clinical research-to put the needs of the consumer first
Simon Denegri
Editorial: Clinical Investigation
-
There should be only one priority in clinical research-to put the needs of the consumer first
Simon Denegri
Editorial: Clinical Investigation
-
Metastatic melanoma can be cured: advances in immunotherapy and targeted approaches
Walter J Urba, Brendan D Curti
Editorial: Clinical Investigation
-
Metastatic melanoma can be cured: advances in immunotherapy and targeted approaches
Walter J Urba, Brendan D Curti
Editorial: Clinical Investigation
-
Metastatic melanoma can be cured: advances in immunotherapy and targeted approaches
Walter J Urba, Brendan D Curti
Editorial: Clinical Investigation
-
Metastatic melanoma can be cured: advances in immunotherapy and targeted approaches
Walter J Urba, Brendan D Curti
Editorial: Clinical Investigation
-
Metastatic melanoma can be cured: advances in immunotherapy and targeted approaches
Walter J Urba, Brendan D Curti
Editorial: Clinical Investigation
-
Metastatic melanoma can be cured: advances in immunotherapy and targeted approaches
Walter J Urba, Brendan D Curti
Editorial: Clinical Investigation
-
Metastatic melanoma can be cured: advances in immunotherapy and targeted approaches
Walter J Urba, Brendan D Curti
Editorial: Clinical Investigation
-
Metastatic melanoma can be cured: advances in immunotherapy and targeted approaches
Walter J Urba, Brendan D Curti
Editorial: Clinical Investigation
-
Emerging medical treatments for actinic keratoses, squamous cell carcinoma and basal cell carcinoma
Nasreen Ghuznavi, Nadia F Nocera, Andrew R Guajardo, Jeffrey M Weinberg
Review: Clinical Trail Outcomes: Clinical Investigation
-
Emerging medical treatments for actinic keratoses, squamous cell carcinoma and basal cell carcinoma
Nasreen Ghuznavi, Nadia F Nocera, Andrew R Guajardo, Jeffrey M Weinberg
Review: Clinical Trail Outcomes: Clinical Investigation
-
Emerging medical treatments for actinic keratoses, squamous cell carcinoma and basal cell carcinoma
Nasreen Ghuznavi, Nadia F Nocera, Andrew R Guajardo, Jeffrey M Weinberg
Review: Clinical Trail Outcomes: Clinical Investigation
-
Emerging medical treatments for actinic keratoses, squamous cell carcinoma and basal cell carcinoma
Nasreen Ghuznavi, Nadia F Nocera, Andrew R Guajardo, Jeffrey M Weinberg
Review: Clinical Trail Outcomes: Clinical Investigation
-
Emerging medical treatments for actinic keratoses, squamous cell carcinoma and basal cell carcinoma
Nasreen Ghuznavi, Nadia F Nocera, Andrew R Guajardo, Jeffrey M Weinberg
Review: Clinical Trail Outcomes: Clinical Investigation
-
Emerging medical treatments for actinic keratoses, squamous cell carcinoma and basal cell carcinoma
Nasreen Ghuznavi, Nadia F Nocera, Andrew R Guajardo, Jeffrey M Weinberg
Review: Clinical Trail Outcomes: Clinical Investigation
-
Emerging medical treatments for actinic keratoses, squamous cell carcinoma and basal cell carcinoma
Nasreen Ghuznavi, Nadia F Nocera, Andrew R Guajardo, Jeffrey M Weinberg
Review: Clinical Trail Outcomes: Clinical Investigation
-
Emerging medical treatments for actinic keratoses, squamous cell carcinoma and basal cell carcinoma
Nasreen Ghuznavi, Nadia F Nocera, Andrew R Guajardo, Jeffrey M Weinberg
Review: Clinical Trail Outcomes: Clinical Investigation
-
Anti-angiogenic therapy for prostate cancer: rationale and ongoing trials
Bamidele A Adesunloye, William L Dahut
Therapeutic Prospective: Clinical Investigation
-
Anti-angiogenic therapy for prostate cancer: rationale and ongoing trials
Bamidele A Adesunloye, William L Dahut
Therapeutic Prospective: Clinical Investigation
-
Anti-angiogenic therapy for prostate cancer: rationale and ongoing trials
Bamidele A Adesunloye, William L Dahut
Therapeutic Prospective: Clinical Investigation
-
Anti-angiogenic therapy for prostate cancer: rationale and ongoing trials
Bamidele A Adesunloye, William L Dahut
Therapeutic Prospective: Clinical Investigation
-
Anti-angiogenic therapy for prostate cancer: rationale and ongoing trials
Bamidele A Adesunloye, William L Dahut
Therapeutic Prospective: Clinical Investigation
-
Anti-angiogenic therapy for prostate cancer: rationale and ongoing trials
Bamidele A Adesunloye, William L Dahut
Therapeutic Prospective: Clinical Investigation
-
Anti-angiogenic therapy for prostate cancer: rationale and ongoing trials
Bamidele A Adesunloye, William L Dahut
Therapeutic Prospective: Clinical Investigation
-
Anti-angiogenic therapy for prostate cancer: rationale and ongoing trials
Bamidele A Adesunloye, William L Dahut
Therapeutic Prospective: Clinical Investigation